Loss of the AE3 anion exchanger in a hypertrophic cardiomyopathy model causes rapid decompensation and heart failure

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 1, 2011, Pages 137-146

  Al Moamen, Nabeel J ^a   Prasad, Vikram ^a   Bodi, Ilona ^a   Miller, Marian L ^a   Neiman, Michelle L ^a   Lasko, Valerie M ^a   Alper, Seth L ^b   Wieczorek, David F ^a   Lorenz, John N ^a   Shull, Gary E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Congestive heart failure; Decompensated; Force frequency response; Pacing; Slc4a3

Indexed keywords

ALPHA TROPOMYOSIN; BICARBONATE; BICARBONATE CHLORIDE ANTIPORTER; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; CHLORIDE ION; GLUTAMIC ACID; GLYCINE; PHOSPHOLAMBAN; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SERINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CALCIUM TRANSPORT; CELL ISOLATION; CHLORIDE TRANSPORT; CONTROLLED STUDY; CROSS BREEDING; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE MUTATION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HEART PERFORMANCE; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; SARCOLEMMA; SURVIVAL RATE; WILD TYPE;

ANIMALS; ANTIPORTERS; CALCIUM; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CARDIOMYOPATHY, HYPERTROPHIC; CATION TRANSPORT PROTEINS; FEMALE; HEART FAILURE; IMMUNOBLOTTING; MALE; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MYOCYTES, CARDIAC; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; SODIUM-HYDROGEN ANTIPORTER;

MUS;

EID: 78650802608     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.10.028     Document Type: Article

References (54)

1. Linn S.C., Kudrycki K.E., Shull G.E. The predicted translation product of a cardiac AE3 mRNA contains an N terminus distinct from that of the brain AE3 Cl-/HCO3- exchanger. Cloning of a cardiac AE3 cDNA, organization of the AE3 gene, and identification of an alternative transcription initiation site. J Biol Chem 1992, 267:7927-7935.
2. Yannoukakos D., Stuart-Tilley A., Fernandez H.A., Fey P., Duyk G., Alper S.L. Molecular cloning, expression, and chromosomal localization of two isoforms of the AE3 anion exchanger from human heart. Circ Res 1994, 75:603-614.
3. Linn S.C., Askew G.R., Menon A.G., Shull G.E. Conservation of an AE3 Cl-/HCO3- exchanger cardiac-specific exon and promoter region and AE3 mRNA expression patterns in murine and human hearts. Circ Res 1995, 76:584-591.
4. Alvarez B.V., Kieller D.M., Quon A.L., Markovich D., Casey J.R. Slc26a6: a cardiac chloride-hydroxyl exchanger and predominant chloride-bicarbonate exchanger of the mouse heart. J Physiol 2004, 561:721-734.
5. Niederer S.A., Swietach P., Wilson D.A., Smith N.P., Vaughan-Jones R.D. Measuring and modeling chloride-hydroxyl exchange in the guinea-pig ventricular myocyte. Biophys J 2008, 94:2385-2403.
6. Vaughan-Jones R.D., Spitzer K.W., Swietach P. Intracellular pH regulation in heart. J Mol Cell Cardiol 2009, 46:318-331.
7. Camilión de Hurtado M.C., Alvarez B.V., Pérez N.G., Ennis I.L., Cingolani H.E. Angiotensin II activates Na+-independent Cl--HCO3- exchange in ventricular myocardium. Circ Res 1998, 82:473-481.
8. Alvarez B.V., Fujinaga J., Casey J.R. Molecular basis for angiotensin II-induced increase of chloride/bicarbonate exchange in the myocardium. Circ Res 2001, 89:1246-1253.
9. Farias F., Morgan P., Chiappe de Cingolani G., Camilión de Hurtado M.C. Involvement of the Na+-independent Cl-/HCO3- exchange (AE) isoform in the compensation of myocardial Na+/H+ isoform 1 hyperactivity in spontaneously hypertensive rats. Can J Physiol Pharmacol 2005, 83:397-404.
10. Lai Z.F., Nishi K. Intracellular chloride activity increases in guinea pig ventricular muscle during simulated ischemia. Am J Physiol Heart Circ Physiol 1998, 275:H1613-H1619.
11. Kawasaki H., Otani H., Mishima K., Imamura H., Inagaki C. Involvement of anion exchange in the hypoxia/reoxygenation-induced changes in pHi and [Ca2+]i in cardiac myocyte. Eur J Pharmacol 2001, 411:35-43.
12. Chiappe de Cingolani G., Morgan P., Mundiña-Weilenmann C., Casey J., Fujinaga J., Camilión de Hurtado M., et al. Hyperactivity and altered mRNA isoform expression of the Cl-/HCO3- anion-exchanger in the hypertrophied myocardium. Cardiovasc Res 2001, 51:71-79.
13. Karmazyn M., Sawyer M., Fliegel L. The Na+/H+ exchanger: a target for cardiac therapeutic intervention. Curr Drug Targets Cardiovasc Haematol Disord 2005, 5:323-335.
14. Prasad V., Bodi I., Meyer J.W., Wang Y., Ashraf M., Engle S.J., et al. Impaired cardiac contractility in mice lacking both the AE3 Cl-/HCO3- exchanger and the NKCC1 Na+-K+-2Cl- cotransporter: effects on Ca2+ handling and protein phosphatases. J Biol Chem 2008, 283:31303-31314.
15. Prabhakar R., Boivin G.P., Grupp I.L., Hoit B., Arteaga G., Solaro R.J., et al. A familial hypertrophic cardiomyopathy α-tropomyosin mutation causes severe cardiac hypertrophy and death in mice. J Mol Cell Cardiol 2001, 33:1815-1828.
16. Thierfelder L., Watkins H., MacRae C., Lamas R., McKenna W., Vosberg H.P., et al. α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994, 77:701-712.
17. Lorenz J.N., Robbins J. Measurement of intraventricular pressure and cardiac performance in the intact closed-chest anesthetized mouse. Am J Physiol Heart Circ Physiol 1997, 272:H1137-H1146.
18. Periasamy M., Reed T.D., Liu L.H., Ji Y., Loukianov E., Paul R.J., et al. Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene. J Biol Chem 1999, 274:2556-2562.
19. D'Angelo D., Sakata Y., Lorenz J.N., Boivin G.P., Walsh R.A., Liggett S.B., et al. Transgenic Gαq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci USA 1997, 94:8121-8126.
20. O'Connell T.D., Ni Y.G., Lin K.-M., Han H., Yan Z. Isolation and culture of adult mouse cardiac myocytes for signaling studies AFCS Research Reports [online] 1(5). http://www.signaling-gateway.org/reports/v1/CM0005/CM0005.htm.
21. MacLennan D.H., Kranias E.G. Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 2003, 4:566-577.
22. Ling H., Zhang T., Pereira L., Means C.K., Cheng H., Gu Y., et al. Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. J Clin Invest 2009, 119:1230-1240.
23. Carr A.N., Schmidt A.G., Suzuki Y., del Monte F., Sato Y., Lanner C., et al. Type 1 phosphatase, a negative regulator of cardiac function. Mol Cell Biol 2002, 22:4124-4135.
24. Chu G., Lester J.W., Young K.B., Luo W., Zhai J., Kranias E.G. A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to β-agonists. J Biol Chem 2000, 275:38938-38943.
25. Hentschke M., Wiemann M., Hentschke S., Kurth I., Hermans-Borgmeyer I., Seidenbecher T., et al. Mice with a targeted disruption of the Cl-/HCO3- exchanger AE3 display a reduced seizure threshold. Mol Cell Biol 2006, 26:182-191.
26. Cingolani H.E., Ennis I.L. Sodium-hydrogen exchanger, cardiac overload, and myocardial hypertrophy. Circulation 2007, 115:1090-1100.
27. Nakamura T.Y., Iwata Y., Arai Y., Komamura K., Wakabayashi S. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure. Circ Res 2008, 103:891-899.
28. Karmazyn M., Kilic A., Javadov S. The role of NHE-1 in myocardial hypertrophy and remodelling. J Mol Cell Cardiol 2008, 44:647-653.
29. Pérez N.G., Alvarez B.V., Camilión de Hurtado M.C., Cingolani H.E. pHi regulation in myocardium of the spontaneously hypertensive rat. Compensated enhanced activity of the Na+-H+ exchanger. Circ Res 1995, 77:1192-1200.
30. Chiappe de Cingolani G.E., Ennis I.L., Morgan P.E., Alvarez B.V., Casey J.R., Camilión de Hurtado M.C. Involvement of AE3 isoform of Na+-independent Cl-/HCO3- exchanger in myocardial pHi recovery from intracellular alkalization. Life Sci 2006, 78:3018-3026.
31. Gawenis L.R., Bradford E.M., Alper S.L., Prasad V., Shull G.E. AE2 Cl-/HCO3- exchanger is required for normal cAMP-stimulated anion secretion in murine proximal colon. Am J Physiol Gastrointest Liver Physiol 2010, 298:G493-G503.
32. Wakabayashi S., Bertrand B., Shigekawa M., Fafournoux P., Pouysségur J. Growth factor activation and "H+-sensing" of the Na+/H+ exchanger isoform 1 (NHE1). Evidence for an additional mechanism not requiring direct phosphorylation. J Biol Chem 1994, 269:5583-5588.
33. Stewart A.K., Kurschat C.E., Vaughan-Jones R.D., Alper S.L. Putative re-entrant loop 1 of AE2 transmembrane domain has a major role in acute regulation of anion exchange by pH. J Biol Chem 2009, 284:6126-6139.
34. Alexander R.T., Grinstein S. Na+/H+ exchangers and the regulation of volume. Acta Physiol 2006, 187:159-167.
35. Jiang L., Chernova M.N., Alper S.L. Secondary regulatory volume increase conferred on Xenopus oocytes by expression of AE2 anion exchanger. Am J Physiol 1997, 272:C191-C202.
36. Petrecca K., Atanasiu R., Grinstein S., Orlowski J., Shrier A. Subcellular localization of the Na+/H+ exchanger NHE1 in rat myocardium. Am J Physiol Heart Circ Physiol 1999, 276:H709-H717.
37. Moura Lima P.R., Salles T.S., Costa F.F., Saad S.T. α-Cardiac actin (ACTC) binds to the band 3 (AE1) cardiac isoform. J Cell Biochem 2003, 89:1215-1221.
38. Mulieri L.A., Hasenfuss G., Leavitt B., Allen P.D., Alpert N.R. Altered myocardial force-frequency relation in human heart failure. Circulation 1992, 85:1743-1750.
39. Neumann J., Eschenhagen T., Jones L.R., Linck B., Schmitz W., Scholz H., et al. Increased expression of cardiac phosphatases in patients with end-stage heart failure. J Mol Cell Cardiol 1997, 29:265-272.
40. De Arcangelis V., Soto D., Xiang Y. Phosphodiesterase 4 and phosphatase 2A differentially regulate cAMP/protein kinase a signaling for cardiac myocyte contraction under stimulation of β1 adrenergic receptor. Mol Pharmacol 2008, 74:1453-1462.
41. Anderson M.E. CaMKII and a failing strategy for growth in heart. J Clin Invest 2009, 119:1082-1085.
42. Grimm M., Brown J.H. β-Adrenergic receptor signaling in the heart: role of CaMKII. J Mol Cell Cardiol 2010, 48:322-330.
43. Antoons G., Vangheluwe P., Volders P.G., Bito V., Holemans P., Ceci M., et al. Increased phospholamban phosphorylation limits the force-frequency response in the MLP-/- mouse with heart failure. J Mol Cell Cardiol 2006, 40:350-360.
44. Hagemann D., Kuschel M., Kuramochi T., Zhu W., Cheng H., Xiao R.P. Frequency-encoding Thr17 phospholamban phosphorylation is independent of Ser16 phosphorylation in cardiac myocytes. J Biol Chem 2000, 275:22532-22536.
45. Huke S., Knollmann B.C. Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility. J Mol Cell Cardiol 2010, 48:824-833.
46. Arai M., Matsui H., Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res 1994, 74:555-564.
47. Bers D.M. Altered cardiac myocyte Ca regulation in heart failure. Physiology 2006, 21:380-387.
48. Houser S.R., Piacentino V., Weisser J. Abnormalities of calcium cycling in the hypertrophied and failing heart. J Mol Cell Cardiol 2000, 32:1595-1607.
49. Bers D.M., Barry W.H., Despa S. Intracellular Na+ regulation in cardiac myocytes. Cardiovasc Res 2003, 57:897-912.
50. Verdonck F., Mubagwa K., Sipido K.R. [Na+] in the subsarcolemmal 'fuzzy' space and modulation of [Ca2+]i and contraction in cardiac myocytes. Cell Calcium 2004, 35:603-612.
51. Swift F., Tovsrud N., Enger U.H., Sjaastad I., Sejersted O.M. The Na+/K+-ATPase α2-isoform regulates cardiac contractility in rat cardiomyocytes. Cardiovasc Res 2007, 75:109-117.
52. Romito A., Lonardo E., Roma G., Minchiotti G., Ballabio A., Cobellis G. Lack of sik1 in mouse embryonic stem cells impairs cardiomyogenesis by down-regulating the cyclin-dependent kinase inhibitor p57kip2. PLoS ONE 2010, 5:e9029.
53. Jaitovich A., Bertorello A.M. Intracellular sodium sensing: SIK1 network, hormone action and high blood pressure. Biochim Biophys Acta 2010, 1802(12):1140-1149.
54. Sjöström M., Stenström K., Eneling K., Zwiller J., Katz A.I., Takemori H., et al. SIK1 is part of a cell sodium-sensing network that regulates active sodium transport through a calcium-dependent process. Proc Natl Acad Sci USA 2007, 104:16922-16927.